Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glucagon like peptide-2 controlled release analog - Entera Bio/OPKO health

Next Previous
Drug Profile

Glucagon like peptide-2 controlled release analog - Entera Bio/OPKO health

Alternative Names: GLP-2 analog - Entera Bio; oral GLP-2 peptide tablet - Entera Bio

Latest Information Update: 20 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Entera Bio; OPKO Health
  • Developer Entera Bio
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon-like peptide 2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Short bowel syndrome

Most Recent Events

  • 09 May 2025 Glucagon like peptide-2 controlled release analog is still in preclinical development for Short-bowel-syndrome in Israel (PO, Tablet)
  • 28 Mar 2025 No recent reports of development identified for preclinical development in Short-bowel-syndrome in Israel (PO, Tablet)
  • 20 Mar 2024 Pharmacokinetic data from preclinical study in Short bowel syndrome released by Entera Bio

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top